INTS vs NUE
Intensity Therapeutics, Inc. Common stock (INTS) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Nucor Corp (NUE) is a steel company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported NUE revenue for 2024-12-31 was $7.08B. Net income was $345.0M. Revenue was down 4.9% from 2024-09-28 to 2024-12-31. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
INTS currently screens at market cap $7.7M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the INTS and NUE stock pages for the full models.
Not investment advice.